Movement Alert｜Oscar Health Rises 5.25% in Pre-Market Trading, Barclays Upgrades Rating to Overweight

Market Focus06-10

On June 10, Oscar Health rose 5.25% in pre-market trading, trading at $28.60/share, with trading volume of approximately $3.99 million.

On the news front, Barclays upgraded Oscar Health from Equal Weight to Overweight, raising its target price from $30 to $35. According to FactSet data, the stock currently carries an average analyst rating of Hold with a mean target price of $22.64. This marks the second consecutive investment bank upgrade in recent weeks, following Wells Fargo's earlier upgrade from Underweight to Equal Weight with a target price increase from $11 to $20 at the beginning of June.

The successive upgrades come alongside strong fundamental momentum. Oscar Health reported Q1 total revenue of $4.65 billion, up 53% year-over-year, with net income of $679 million and EPS of $2.07, significantly exceeding the consensus estimate of $1.10. Membership reached 3.2 million, up 56% year-over-year. The combination of consecutive analyst upgrades and robust earnings performance continues to drive the stock higher from its earlier lows.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1100730753?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-10 21:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100730753","market":"us","top_or_hot":-1,"title":"Movement Alert｜Oscar Health Rises 5.25% in Pre-Market Trading, Barclays Upgrades Rating to Overweight","media":"Market Focus","content":"<p><p>On June 10, Oscar Health rose 5.25% in pre-market trading, trading at $28.60/share, with trading volume of approximately $3.99 million.</p><p>On the news front, Barclays upgraded Oscar Health from Equal Weight to Overweight, raising its target price from $30 to $35. According to FactSet data, the stock currently carries an average analyst rating of Hold with a mean target price of $22.64. This marks the second consecutive investment bank upgrade in recent weeks, following Wells Fargo's earlier upgrade from Underweight to Equal Weight with a target price increase from $11 to $20 at the beginning of June.</p><p>The successive upgrades come alongside strong fundamental momentum. Oscar Health reported Q1 total revenue of $4.65 billion, up 53% year-over-year, with net income of $679 million and EPS of $2.07, significantly exceeding the consensus estimate of $1.10. Membership reached 3.2 million, up 56% year-over-year. The combination of consecutive analyst upgrades and robust earnings performance continues to drive the stock higher from its earlier lows.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Oscar Health Rises 5.25% in Pre-Market Trading, Barclays Upgrades Rating to Overweight</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Oscar Health Rises 5.25% in Pre-Market Trading, Barclays Upgrades Rating to Overweight\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-10 21:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 10, Oscar Health rose 5.25% in pre-market trading, trading at $28.60/share, with trading volume of approximately $3.99 million.</p><p>On the news front, Barclays upgraded Oscar Health from Equal Weight to Overweight, raising its target price from $30 to $35. According to FactSet data, the stock currently carries an average analyst rating of Hold with a mean target price of $22.64. This marks the second consecutive investment bank upgrade in recent weeks, following Wells Fargo's earlier upgrade from Underweight to Equal Weight with a target price increase from $11 to $20 at the beginning of June.</p><p>The successive upgrades come alongside strong fundamental momentum. Oscar Health reported Q1 total revenue of $4.65 billion, up 53% year-over-year, with net income of $679 million and EPS of $2.07, significantly exceeding the consensus estimate of $1.10. Membership reached 3.2 million, up 56% year-over-year. The combination of consecutive analyst upgrades and robust earnings performance continues to drive the stock higher from its earlier lows.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OSCR","symbol_name":"Oscar Health, Inc.","start_time":0,"source_url":"","article_id":"1100730753","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100730753","pubTimestamp":1781097333,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 10, Oscar Health rose 5.25% in pre-market trading, trading at $28.60/share, with trading volume of approximately $3.99 million.On the news front, Barclays upgraded Oscar Health from Equal...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OSCR":"Oscar Health, Inc."},"translate_title":"动向提示|Oscar Health盘前涨5.25%巴克莱上调评级至跑赢大盘","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSCR":1},"content_text":"On June 10, Oscar Health rose 5.25% in pre-market trading, trading at $28.60/share, with trading volume of approximately $3.99 million.On the news front, Barclays upgraded Oscar Health from Equal Weight to Overweight, raising its target price from $30 to $35. According to FactSet data, the stock currently carries an average analyst rating of Hold with a mean target price of $22.64. This marks the second consecutive investment bank upgrade in recent weeks, following Wells Fargo's earlier upgrade from Underweight to Equal Weight with a target price increase from $11 to $20 at the beginning of June.The successive upgrades come alongside strong fundamental momentum. Oscar Health reported Q1 total revenue of $4.65 billion, up 53% year-over-year, with net income of $679 million and EPS of $2.07, significantly exceeding the consensus estimate of $1.10. Membership reached 3.2 million, up 56% year-over-year. The combination of consecutive analyst upgrades and robust earnings performance continues to drive the stock higher from its earlier lows.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1100730753","isCrawlerRequest":true}